AAAAAA

   
Results: 1-11 |
Results: 11
Epimerization of peptide nucleic acids analogs during solid-phase synthesis: optimization of the coupling conditions for increasing the optical purity
Authors: Corradini, R Sforza, S Dossena, A Palla, G Rocchi, R Filira, F Nastri, F Marchelli, R
Citation: R. Corradini et al., Epimerization of peptide nucleic acids analogs during solid-phase synthesis: optimization of the coupling conditions for increasing the optical purity, J CHEM S P1, (20), 2001, pp. 2690-2696
Influence of glycosylation on the conformational preferences of folded oligopeptides
Authors: Gobbo, M Nicotra, A Rocchi, R Crisma, M Toniolo, C
Citation: M. Gobbo et al., Influence of glycosylation on the conformational preferences of folded oligopeptides, TETRAHEDRON, 57(12), 2001, pp. 2433-2443
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study
Authors: Marcocci, C Bartalena, L Tanda, ML Manetti, L Dell'Unto, E Rocchi, R Barbesino, G Mazzi, B Bartolomei, MP Lepri, P Cartei, F Nardi, M Pinchera, A
Citation: C. Marcocci et al., Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study, J CLIN END, 86(8), 2001, pp. 3562-3567
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids
Authors: Bartalena, L Manetti, L Tanda, ML Dell'Unto, E Mazzi, B Rocchi, R Barbesino, G Pinchera, A Marcocci, C
Citation: L. Bartalena et al., Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids, CLIN ENDOCR, 52(5), 2000, pp. 647-651
Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases
Authors: Juliano, MA Filira, F Gobbo, M Rocchi, R Del Nery, E Juliano, L
Citation: Ma. Juliano et al., Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases, J PEPT RES, 53(2), 1999, pp. 109-119
Graves' ophthalmopathy and I-131 therapy
Authors: Marcocci, C Bartalena, L Tanda, ML Manetti, L Dell'Unto, E Mazzi, B Rocchi, R Barbesino, G Pinchera, A
Citation: C. Marcocci et al., Graves' ophthalmopathy and I-131 therapy, Q J NUCL M, 43(4), 1999, pp. 307-312
Pharmacological activities of cyclic bradykinin analogues
Authors: Piek, T Le Corronc, H Gobbo, M Hue, B Mantel, P Rocchi, R
Citation: T. Piek et al., Pharmacological activities of cyclic bradykinin analogues, NEUROSC R C, 24(2), 1999, pp. 117-123
Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, but its immunological effects must be taken into account
Authors: Chiovato, L Rocchi, R Fiore, E
Citation: L. Chiovato et al., Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, but its immunological effects must be taken into account, J ENDOC INV, 22(4), 1999, pp. 310-312
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia
Authors: Battistini, S Stenirri, S Piatti, M Gelfi, C Righetti, PG Rocchi, R Giannini, F Battistini, N Guazzi, GC Ferrari, M Carrera, P
Citation: S. Battistini et al., A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia, NEUROLOGY, 53(1), 1999, pp. 38-43
Dermorphin and deltorphin glycosylated analogues: Synthesis and antinociceptive activity after systemic administration
Authors: Negri, L Lattanzi, R Tabacco, F Orru, L Severini, C Scolaro, B Rocchi, R
Citation: L. Negri et al., Dermorphin and deltorphin glycosylated analogues: Synthesis and antinociceptive activity after systemic administration, J MED CHEM, 42(3), 1999, pp. 400-404
Crystal structure of a fully protected beta-O-galactosylated tripeptide
Authors: Crisma, M Gobbo, M Toniolo, C Rocchi, R
Citation: M. Crisma et al., Crystal structure of a fully protected beta-O-galactosylated tripeptide, CARBOHY RES, 315(3-4), 1999, pp. 334-338
Risultati: 1-11 |